Search - tctmd.com

Displaying 301 - 320 of 1262

Sort: Relevancy | Date

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Daily News

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

Shelley Wood

May 30, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News ESOC 2023

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

Todd Neale

May 26, 2023

News Conference News SCAI 2023

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

L.A. McKeown

May 25, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Draft Guidance Reflects FDA’s Thinking Around Decentralized Trials

Todd Neale

May 04, 2023

News Daily News

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

Michael O'Riordan

May 01, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

AI Gleans Insights Into Statin Questions, Misinformation Online

L.A. McKeown

April 26, 2023

News Daily News

CVD Risks After Pregnancy Linked to Prenatal Depression

L.A. McKeown

April 21, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

Shelley Wood

April 12, 2023

News Daily News

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Yael L. Maxwell

April 12, 2023

News Daily News

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

L.A. McKeown

April 12, 2023

News Daily News

Inactivity Pandemic Poised to Undo CVD Prevention Advances

Michael O'Riordan

April 11, 2023

News Daily News

AHA Urges Holistic Cardiovascular Care of Women, With Focus on Race/Ethnicity

Yael L. Maxwell

April 10, 2023

Advertisement

FDA Approves Colchicine for Decreasing CV Events

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Sotagliflozin Gets FDA Approval in HF Across EF Spectrum

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Surgery and ‘Care-Bundle’ Trials Raise Hopes for ICH Care

CLIPPER Attempts to Draw Out Useful Quality Metrics for CLTI

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Draft Guidance Reflects FDA’s Thinking Around Decentralized Trials

Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes

May 2023 News Roundup

AI Gleans Insights Into Statin Questions, Misinformation Online

CVD Risks After Pregnancy Linked to Prenatal Depression

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

REPRIEVE Stopped: Big MACE Reductions With Statins in HIV+ Subjects

To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC

Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows

Inactivity Pandemic Poised to Undo CVD Prevention Advances

AHA Urges Holistic Cardiovascular Care of Women, With Focus on Race/Ethnicity

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content